Industry Verticals »

All Categories

Insights »

About TMR »

Hemostasis and Tissue Sealing Agents Market

Hemostasis and Tissue Sealing Agents Market (Topical Hemostats - Mechanical Hemostats, Active Hemostats & Flowable Hemostats and Adhesive and Tissue Sealing Agents - Natural Tissue Sealants, Synthetic Tissue Sealants & Adhesion Barrier Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global hemostasis and tissue sealing agents market for the historical period 2017–2018 and forecast period 2019–2027, a rise in demand for minimally invasive procedures and an increase in the global geriatric population are projected to drive the global market for hemostasis and tissue sealing agents during the forecast period
  • According to the report, the global hemostasis & tissue sealing agents market was valued at US$ 5.1 Bn in 2018 and is anticipated to expand at a CAGR of 8.3% from 2019 to 2027

Rise in demand for minimally invasive procedures: Key Drivers

  • The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications, and shorter recovery time. Systemic hemostatic agents such as gelatin and collagen-based hemostat powders are widely used in minimally invasive procedures. These agents enable surgeons to perform complex surgeries.
  • According to a study conducted by the World Health Organization (WHO), approximately 234.2 million major surgical procedures are undertaken by various hospitals and surgical centers across the world each year. Thus, the rising number of surgical procedures and growing preference for minimally invasive procedures boost the demand for the Hemostasis and tissue sealing agents market.

The aging population increases the number of surgeries needing hemostat products boosting the market growth

  • Treatment services have become affordable due to improvements in healthcare policies in countries such as the U.S., Japan, the U.K., and China. This, in turn, has increased the life expectancy of the population. Consequently, the rise in the geriatric population increases the number of surgical procedures that use adhesion barriers and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000.
  • The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostats, tissue sealants, and adhesion barrier products and boosts market growth.

High cost and strict regulatory requirements to Hamper Market

  • Hemostat and tissue sealant product development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidence, well-controlled investigations, and documented case studies. Despite the high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. The low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market.

Global Hemostasis and tissue sealing agents Market: Competitive Landscape

  • This report profiles major players in the global hemostasis and tissue sealing agents industry based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global Hemostasis and tissue sealing agents market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global Hemostasis and tissue sealing agents business are
    • Advanced Medical Solutions Group plc
    • Baxter
    • Cohera Medical, Inc.
    • CryoLife, Inc.
    • C.R. Bard, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
    • Pfizer, Inc.
    • Cohesion Technologies Inc.
    • B Braun Medical Inc
    • other prominent players.

Global Hemostasis and Tissue Sealing Agents Industry: Key Developments

Key players in the global hemostasis and tissue sealing agents market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few expansion strategies adopted by players operating in the global market for Hemostasis and tissue sealing agents are:

  • In July 2020, Sysmex Corporation launched a new product in the hemostasis field i.e. Automated Blood Coagulation Analyzers, which is used for chemiluminescence enzyme immunoassay to enhance testing workflow efficiency
  • On January 26, 2020, Terumo Corporation launched a new surgical sealant product i.e. AQUABRID in EMEA Market. This product helps to stop bleeding during aortic surgical procedures.
  • In January 2018, Baxter acquired two hemostat and sealant products i.e. RECOTHROM and PREVELEAK from Mallinckrodt plc for broadening the portfolio of innovative surgical products.

The report on the global market for hemostasis and tissue sealing agents discussed individual strategies, followed by company profiles of manufacturers of hemostasis and tissue sealing agents. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global hemostasis and tissue sealing agents market.

Frequently Asked Questions

What is the total market worth of hemostasis and tissue sealing agents market?

The global market for Hemostasis and tissue sealing agents to reach the valuation of US$ 10.3 Bn by 2027

What is the anticipated CAGR of the hemostasis & tissue sealing agents market in the forecast period?

The global market is anticipated to expand at a CAGR of 8.3% from 2019 to 2027

What are the key driving factors for the growth of the global market for hemostasis and tissue sealing agents?

Hemostasis & tissue sealing agents market is driven by a rise in demand for minimally invasive procedures and an increase in the global geriatric population

Which region is expected to project the highest market share in the global hemostasis and tissue sealing agents business?

North America held the largest share of the global market for hemostasis and tissue-sealing agents

Who are the key players in the global hemostasis and tissue sealing agents business?

Key players in the hemostasis and tissue sealing agents market include Advanced Medical Solutions Group PLC, Cohera Medical, Inc., C. R. Bard, Inc., Integra Life Sciences Corporation, Cohesion Technologies Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemostasis and Tissue Sealing Agents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Development in the Market

    5.2. Mergers & Acquisitions

    5.3. COVID-19 Impact Analysis

6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Type, 2017–2027

        6.2.1. Topical Hemostat

            6.2.1.1. Mechanical Hemostats

                6.2.1.1.1. Collagen based Topical Hemostats

                6.2.1.1.2. ORC based Topical Hemostats

                6.2.1.1.3. Gelatin based Topical Hemostats

                6.2.1.1.4. Polysaccharide based Topical Hemostats

            6.2.1.2. Active Hemostats

            6.2.1.3. Flowable Hemostats

        6.2.2.  Adhesive and Tissue Sealing Agents

            6.2.2.1. Natural Tissue Sealant

            6.2.2.2. Synthetic Tissue Sealant

            6.2.2.3. Adhesion Barrier Products

    6.3. Global Hemostasis and Tissue Sealing Agents Market Analysis, by Type

    6.4. Global Hemostasis and Tissue Sealing Agents Market Attractiveness, by Type

7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Region

        7.2.1. North America

        7.2.2. Europe

        7.2.3. Asia Pacific

        7.2.4. Latin America

        7.2.5. Middle East & Africa

    7.3. North America Hemostasis and Tissue Sealing Agents Market Attractiveness, by Region

8. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        8.2.1. Topical Hemostat

            8.2.1.1. Mechanical Hemostats

                8.2.1.1.1. Collagen based Topical Hemostats

                8.2.1.1.2. ORC based Topical Hemostats

                8.2.1.1.3. Gelatin based Topical Hemostats

                8.2.1.1.4. Polysaccharide based Topical Hemostats

            8.2.1.2. Active Hemostats

            8.2.1.3. Flowable Hemostats

        8.2.2.  Adhesive and Tissue Sealing Agents

            8.2.2.1. Natural Tissue Sealant

            8.2.2.2. Synthetic Tissue Sealant

            8.2.2.3. Adhesion Barrier Products

    8.3. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country, 2017–2027

        8.3.1. U.S.

        8.3.2. Canada

    8.4. North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        8.4.1. By Type

        8.4.2. By Country

9. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        9.2.1. Topical Hemostat

            9.2.1.1. Mechanical Hemostats

                9.2.1.1.1. Collagen based Topical Hemostats

                9.2.1.1.2. ORC based Topical Hemostats

                9.2.1.1.3. Gelatin based Topical Hemostats

                9.2.1.1.4. Polysaccharide based Topical Hemostats

            9.2.1.2. Active Hemostats

            9.2.1.3. Flowable Hemostats

        9.2.2.  Adhesive and Tissue Sealing Agents

            9.2.2.1. Natural Tissue Sealant

            9.2.2.2. Synthetic Tissue Sealant

            9.2.2.3. Adhesion Barrier Products

    9.3. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        9.4.1. By Type

        9.4.2. By Country/Sub-region

10. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.2.1. Topical Hemostat

            10.2.1.1. Mechanical Hemostats

                10.2.1.1.1. Collagen based Topical Hemostats

                10.2.1.1.2. ORC based Topical Hemostats

                10.2.1.1.3. Gelatin based Topical Hemostats

                10.2.1.1.4. Polysaccharide based Topical Hemostats

            10.2.1.2. Active Hemostats

            10.2.1.3. Flowable Hemostats

        10.2.2.  Adhesive and Tissue Sealing Agents

            10.2.2.1. Natural Tissue Sealant

            10.2.2.2. Synthetic Tissue Sealant

            10.2.2.3. Adhesion Barrier Products

    10.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        10.4.1. By Type

        10.4.2. By Country/Sub-region

11. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.2.1. Topical Hemostat

            11.2.1.1. Mechanical Hemostats

                11.2.1.1.1. Collagen based Topical Hemostats

                11.2.1.1.2. ORC based Topical Hemostats

                11.2.1.1.3. Gelatin based Topical Hemostats

                11.2.1.1.4. Polysaccharide based Topical Hemostats

            11.2.1.2. Active Hemostats

            11.2.1.3. Flowable Hemostats

        11.2.2.  Adhesive and Tissue Sealing Agents

            11.2.2.1. Natural Tissue Sealant

            11.2.2.2. Synthetic Tissue Sealant

            11.2.2.3. Adhesion Barrier Products

    11.3. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America Latin America

    11.4. Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        11.4.1. By Type

        11.4.2. By Country/Sub-region

12. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.2.1. Topical Hemostat

            12.2.1.1. Mechanical Hemostats

                12.2.1.1.1. Collagen based Topical Hemostats

                12.2.1.1.2. ORC based Topical Hemostats

                12.2.1.1.3. Gelatin based Topical Hemostats

                12.2.1.1.4. Polysaccharide based Topical Hemostats

            12.2.1.2. Active Hemostats

            12.2.1.3. Flowable Hemostats

        12.2.2.  Adhesive and Tissue Sealing Agents

            12.2.2.1. Natural Tissue Sealant

            12.2.2.2. Synthetic Tissue Sealant

            12.2.2.3. Adhesion Barrier Products

    12.3. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

        12.4.1. By Application

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by Tier and Size of companies)

    13.2. Market Share / Position Analysis, by Company, 2019

    13.3. Company Profiles

        13.3.1. Advanced Medical Solutions Group plc  

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Financial Analysis

            13.3.1.3. Growth Strategies

            13.3.1.4. SWOT Analysis

        13.3.2. Baxter

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Financial Analysis

            13.3.2.3. Growth Strategies

            13.3.2.4. SWOT Analysis

        13.3.3. Cohera Medical, Inc .

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Financial Analysis

            13.3.3.3. Growth Strategies

            13.3.3.4. SWOT Analysis

        13.3.4. CryoLife, Inc .

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Financial Analysis

            13.3.4.3. Growth Strategies

            13.3.4.4. SWOT Analysis

        13.3.5. C.R. Bard, Inc  

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Financial Analysis

            13.3.5.3. Growth Strategies

            13.3.5.4. SWOT Analysis

        13.3.6. Johnson & Johnson Services, Inc  

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Financial Analysis

            13.3.6.3. Growth Strategies

            13.3.6.4. SWOT Analysis

        13.3.7. Integra LifeSciences Corporation.

            13.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Financial Analysis

            13.3.7.3. Growth Strategies

            13.3.7.4. SWOT Analysis

        13.3.8. Pfizer, Inc.  

            13.3.8.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Financial Analysis

            13.3.8.3. Growth Strategies

            13.3.8.4. SWOT Analysis

        13.3.9. Cohesion Technologies Inc.  

            13.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Financial Analysis

            13.3.9.3. Growth Strategies

            13.3.9.4. SWOT Analysis

        13.3.10. B Braun Medical Inc.  

            13.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Financial Analysis

            13.3.10.3. Growth Strategies

            13.3.10.4. SWOT Analysis

        13.3.11. Other prominent Players

List of Table

Table 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017–2027

Table 02: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 03: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 04: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 05: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

Table 07: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 08: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 09: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 10: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country, 2017-2027

Table 11: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

Table 12: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 13: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 14: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 15: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 16: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

Table 17: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 18: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 19: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 20: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 21: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

Table 22: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 23: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 24: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 25: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 26: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

Table 27: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

Table 28: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

Table 29: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

Table 30: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figure

Figure 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2019–2027

Figure 02: Market Value Share, by Type (2018)

Figure 04: Market Value Share, by Region (2018)

Figure 05: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 06: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Hemostat, 2017–2027

Figure 07: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Adhesive and Tissue Sealing Agents, 2017–2027

Figure 08: Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

Figure 09: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Region, 2018 and 2027

Figure 10: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Region 2019-2027

Figure 11: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027

Figure 12: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 13: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027

Figure 14: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027

Figure 15: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027

Figure 16: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 17: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 18: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 19: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

Figure 20: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

Figure 21: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 22: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 23: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 24: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

Figure 25: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

Figure 26: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027

Figure 27: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 28: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027

Figure 29: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027

Figure 30: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027

Figure 31: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 32: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

Figure 33: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 34: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

Figure 35: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

Figure 36: Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Company (2019)

Copyright © Transparency Market Research, Inc. All Rights reserved

Hemostasis and Tissue Sealing Agents Market

Schedule a Call